An Australian researcher went undercover to learn more about how Broscience experiments with dangerous drugs — and found a ...

G-protein coupled receptors (GPCRs) are proteins triggered by ligands (protein-binding chemicals) from outside cells to ...

State-of-the-art AI programs can support the development of drugs by predicting how proteins interact with small molecules. However, a new study by researchers at the University of Basel published in ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...

Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

Duke researchers have developed a new AI-powered approach to nanoparticle drug delivery design, which performed well in lab tests with cancer drugs Drugs that fight diseases work best when they reach ...

Biomedical engineers at Duke University have developed a platform that combines automated wet lab techniques with artificial intelligence (AI) to design nanoparticles for drug delivery. The approach ...

Molecular modeling soon attracted the attention of Medicinal Chemistry researchers, given the importance of molecular structure for understanding the mode of action and for designing bioactive ...

In 1962, the Congress vested the Food and Drug Administration (FDA) with the authority to regulate prescription drug advertising. These advertisements can mislead the public about the risks and ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...